Spyre Therapeutics, Inc SYRE
NASDAQ · United States · Health Technology
$89.93+0.90 (+1.01%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-04 | -0.36 | -0.76 | +52.6% | $0 | — | +9.9%$94.93→$104.35 |
| Q1 2026 | 2026-05-05 | -0.74 | -0.66 | -12.1% | — | — | +5.6%$69.13→$73.00 |
| Q4 2025 | 2026-02-19 | -0.74 | -0.80 | +7.5% | — | — | +18.1%$36.60→$43.21 |
| Q3 2025 | 2025-11-04 | -0.15 | -0.68 | +77.9% | — | — | -3.9%$23.78→$22.85 |
| Q4 2023 | 2024-02-29 | -4.05 | -0.83 | -388.0% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.